Drug intelligence / Profile preview

sodium chloride (MIP Pharma)

Development stage: Unknown
Lead developer: MIP Pharma
Modality: Small Molecules
Administration: Intranasal

Overview

Tetrisal E is an isotonic saline nasal spray containing 0.9% sodium chloride. It is used for the treatment of nasal congestion, the moisturizing of dry nasal mucosa, and general nasal hygiene. The solution works by thinning nasal secretions and facilitating the mechanical removal of mucus, crusts, and environmental irritants. Marketed by MiP Pharma (often associated with Rosen Pharma) in Germany, it is an over-the-counter (OTC) product suitable for infants, children, and adults. It does not contain preservatives or decongestant medications, making it suitable for long-term use.

Brand names: Tetrisal E
Other names: isotonic saline solutionsaline

Beyond the preview

Go deeper on sodium chloride (MIP Pharma).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on sodium chloride (MIP Pharma).

Explore the full profile